Page last updated: 2024-12-11
a 70450
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
A 70450: inhibitor of aspartyl proteinase [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 22844441 |
| SCHEMBL ID | 7343870 |
| MeSH ID | M0221181 |
Synonyms (8)
| Synonym |
|---|
| a 70450 |
| 142928-23-2 |
| 2-(3-benzyl-4-n-(4-methylpiperazin-1-yl-carbonyl)-2-ketopiperazin-1-yl)hexanoic acid amide |
| cyclohexanehexanamide, delta-amino-n-butyl-gamma-hydroxy-alpha-(1-methylethyl)-, monohydrochloride, (alphar-(alphar*,gammas*,deltas*))- |
| SCHEMBL7343870 |
| 5-amino-n-butyl-6-cyclohexyl-4-hydroxy-2-(propan-2-yl)hexanimidic acid--hydrogen chloride (1/1) |
| DTXSID60931684 |
| (2r,4s,5s)-5-amino-n-butyl-6-cyclohexyl-4-hydroxy-2-propan-2-ylhexanamide;hydrochloride |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (20.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 4 (80.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||